Yongding Wu

机构：Fujian Medical University, First Affiliated Hospital of Guangzhou Medical University, Guangzhou First People's Hospital, Fujian Provincial Hospital, South China University of Technology, Guangzhou Medical University · ORCID：0009-0000-4874-2589

发表论文 75 篇 · 总被引 894 次 · h-index 15

代表论文

• Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer (2025 · Drug Resistance Updates · 被引 38)
• Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer (2024 · Molecular Cancer · 被引 31)
• Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation (2025 · Cancer Letters · 被引 13)
• Targeting SERPINB3–MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy (2025 · Molecular Cancer · 被引 11)
• Targeting CLK1/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy (2025 · Drug Resistance Updates · 被引 10)
• TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis (2025 · Cancer Research · 被引 7)